Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Crohn Disease 1

Interventions

Certolizumab Pegol 5 MEDI2070 2 Infliximab 2 Adalimumab 2 secukinumab 1 golimumab 1 Ustekinumab 1 CT-P13 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Crohn Disease × Ustekinumab × Clear all

NCT04655807 2025-04-27

DUET

Janssen Research & Development, LLC

Phase 2 Withdrawn

Crohn Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡